Total pain's evaluation (TPE) in 40 AIDS patients with cancer (Meeting abstract).

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Total pain's evaluation (TPE) in 40 AIDS patients with cancer (Meeting abstract).

Proc Annu Meet Am Soc Clin Oncol; 15:A856 1996. Unique Identifier : AIDSLINE ICDB/97635856
Litovska S; Navigante A; Marantz A; Lewi D; Fernandez Hospital, Buenos Aires, Argentina

Abstract: Without a cure on the horizon there is a need to identify ways to sustain hope, existential and spiritual well being in pts with AIDS and cancer (Carson V, Perspect Psychiatr Care; 26(2):28-34 1990). Proposal of the method to evaluate the total pain was published in Proc Asco; 11:386 1992. Despite the importance of the sense of life, the transcendency, most of the existing scales do not assess spirituality. 'We suggest that the spiritual domain also needs to be tapped' (Donovan KJ, Clin Onc; 7(7):959-62 1989). In this study the TPE was used in 40 pts. 32/40 had Kaposi's sarcoma and 8/40 had non-Hodgkin's lymphoma (The major risk factors for HIV are homos cont in 29, IVDU in 8, heter cont in 3). 15% of pts have a maladjusted response in the spiritual aspects (without sense of life). So in 85% of pts may be sustained hope in spite of the human suffering of the AIDS and cancer. This technological and moral crisis that extends to the present medicine (as the AIDS crisis is demonstrated so well) sometimes, dehumanized, in which the spirituality of pts seems to be ignored as exemplified by Young D (J Nat Can Inst; 84(10):810 1992) as follows: 'There are physicians who disregard the ethical principles in order to maintain a very lucrative chemotherapy practice. I believe that the time has come to publish a code of ethical standards.'

Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS/*PHYSIOPATHOLOGY Ethics, Medical Human Neoplasms/COMPLICATIONS/*PHYSIOPATHOLOGY Pain/*ETIOLOGY/THERAPY *Pain Measurement Palliative Care Quality of Life ABSTRACT
970330
M9731532

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .